Möglichkeiten und Restriktionen einer umweltorientierten kommunalen Verkehrspolitik ― dargestellt am Beispiel Freiburg im Breisgau = Possibilités et limites d'une politique communale des transports à orientation environnementaleBLATTER, J.Archiv für Kommunalwissenschaften. 1994, Vol 33, Num 2, pp 317-341, issn 0003-9209Article

THE SET OF CONTINUOUS SELECTIONS OF A METRIC PROJECTION IN C(X)BLATTER J; SCHUMAKER L.1982; J. APPROX. THEORY; ISSN 0021-9045; USA; DA. 1982; VOL. 36; NO 2; PP. 141-155; BIBL. 9 REF.Article

THE INHOMOGENEOUS DIAMAGNETISM AT AN IMPURITY IN A FREE-ELECTRON GASBLATTER J; HEUER M.1982; JOURNAL OF PHYSICS. C. SOLID STATE PHYSICS; ISSN 0022-3719; GBR; DA. 1982; VOL. 15; NO 4; PP. 747-754; BIBL. 8 REF.Article

Unique continuous selections for metric projections of C(X) onto finite-dimensional vector subspacesBLATTER, J.Journal of approximation theory. 1990, Vol 61, Num 2, pp 194-221, issn 0021-9045Article

CONTINUOUS SELECTIONS AND MAXIMAL ALTERNATORS FOR SPLINE APPROXIMATIONBLATTER J; SCHUMAKER L.1983; JOURNAL OF APPROXIMATION THEORY; ISSN 0021-9045; USA; DA. 1983; VOL. 38; NO 1; PP. 71-80; BIBL. 7 REF.Article

Premières modifications de la loi MéhaignerieBLATTER, J.-P.Actualité Juridique (L'). Propriété Immobilière. 1989, Num 1, pp 28-61Article

Preclinical evaluation of a radiosensitizing effect of gemcitabine in p53 mutant and p53 wild type bladder cancer cellsFECHNER, G; PERABO, F. G. E; SCHMIDT, D. H et al.Urology (Ridgewood, NJ). 2003, Vol 61, Num 2, pp 468-473, issn 0090-4295, 6 p.Article

PHENOMENOLOGICAL DERIVATION OF THE DIELECTRIC FUNCTION OF DISORDERED CONDUCTORSHELMAN JS; DEL CASTILLO MUSSOT M; BALTENSPERGER W et al.1980; HELV. PHYS. ACTA; ISSN 0018-0238; CHE; DA. 1980; VOL. 52; NO 5-6; PP. 632-636; BIBL. 8 REF.Article

Schizophrenia trials in China : a surveyCHAKRABARTI, A; ADAMS, C. E; BLATTER, J et al.Acta psychiatrica Scandinavica. 2007, Vol 116, Num 1, pp 6-9, issn 0001-690X, 4 p.Article

The efficacy of 2', 2'-difluorodeoxycytidine (gemcitabine) and vinblastine combined with interferon in nude mice xenografts of human renal cell carcinomaROHDE, D; GOERTZ, M; BLATTER, J et al.International journal of oncology. 1998, Vol 12, Num 6, pp 1367-1372, issn 1019-6439Article

A phase II trial of gemcitabine and ifosfamide in non-small cell lung cancerGATZEMEIER, U; MANEGOLD, C; EBERHARD, W et al.Seminars in oncology. 1997, Vol 24, Num 3, pp S8-36, issn 0093-7754, -S8-38, SUP8Article

Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, pemetrexed disodium, ALIMTA) and cisplatin : A multicenter phase II trialMANEGOLD, C; GATZEMEIER, U; VON PAWEL, J et al.Annals of oncology. 2000, Vol 11, Num 4, pp 435-440, issn 0923-7534Article

Gemcitabine in non-small cell lung cancer (NSCLC)MANEGOLD, C; ZATLOUKAL, P; KREJCY, K et al.Investigational new drugs. 2000, Vol 18, Num 1, pp 29-42, issn 0167-6997Article

Fluorodeoxyglucose uptake in vitro : aspects of method and effects of treatment with gemcitabineHABERKORN, U; MORR, I; OBERDORFER, F et al.JNM. The journal of nuclear medicine (1990). 1994, Vol 35, Num 11, pp 1842-1850Article

Erlotinib in combination with pemetrexed for patients with advanced non-small-cell lung cancer (NSCLC): a phase I dose-finding studyRANSON, M; RECK, M; ANTHONEY, A et al.Annals of oncology. 2010, Vol 21, Num 11, pp 2233-2239, issn 0923-7534, 7 p.Article

Malignant peritoneal mesothelioma-Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agentCARTENI, G; MANEGOLD, C; GARCIA, G. Martin et al.Lung cancer. 2009, Vol 64, Num 2, pp 211-218, issn 0169-5002, 8 p.Article

A phase II trial of pemetrexed in patients with metastatic renal cancerTHÖDTMANN, R; SAUTER, T; WEINKNECHT, S et al.Investigational new drugs. 2003, Vol 21, Num 3, pp 353-358, issn 0167-6997, 6 p.Article

The efficacy of 2', 2'-difluorodeoxycytidine (gemcitabine) combined with interferon in human renal cell carcinoma cell linesROHDE, D; HAYN, H. K; BLATTER, J et al.International journal of oncology. 1998, Vol 12, Num 6, pp 1361-1366, issn 1019-6439Article

Ifosfamide and gemcitabine : A phase II trial in advanced inoperable non-small cell lung cancerGATZEMEIER, U; MANEGOLD, C; EBERHARD, W et al.Seminars in oncology. 1998, Vol 25, Num 1, pp 15-18, issn 0093-7754, SUP2Conference Paper

Clinical and pharmacokinetic phase I study of multitargeted antifolate (LY231514) in combination with cisplatinTHÖDTMANN, R; DEPENBROCK, H; DUMEZ, H et al.Journal of clinical oncology. 1999, Vol 17, Num 10, pp 3009-3016, issn 0732-183XArticle

PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabineHABERKORN, U; BELLEMANN, M. E; ALTMANN, A et al.The Journal of nuclear medicine (1978). 1997, Vol 38, Num 8, pp 1215-1221, issn 0161-5505Article

Gemcitabine and etoposide in small cell lung cancer : Phase I and II trialsRASSMANN, I; THÖDTMANN, R; DEPENBROCK, H et al.Seminars in oncology. 1997, Vol 24, Num 2, pp S7-75, issn 0093-7754, -S7-78, SUP7Article

Gemcitabine : a phase II study in patients with advanced renal cancerDE MULDER, P. H. M; WEISSBACH, L; JAKSE, G et al.Cancer chemotherapy and pharmacology. 1996, Vol 37, Num 5, pp 491-495, issn 0344-5704Article

Art of the holocaustBLATTER, J; MILTON, S; FRIEDLANDER, H et al.1982, 272 p.Book

Gemcitabine plus etoposide in chemonaive extensive disease small-cell lung cancer: A multi-centre phase II studyVANSTEENKISTE, J; GATZEMEIER, U; MANEGOLD, C et al.Annals of oncology. 2001, Vol 12, Num 6, pp 835-840, issn 0923-7534Article